William Blair & Company’s Axogen AXGN Stock Holding History

William Blair & Company’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-8,492	Closed	-$240K	–	1518
2017 Q4	$240K	Buy	+8,492	New	+$200K	﹤0.01%	1206

Other funds holding AXGN

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

William Blair & Company's AXGN Position: Q1 2018 in Review

William Blair & Company sold out of Axogen (AXGN) in Q1 2018, closing a stake of 8,492 shares — an estimated $240K sold.

William Blair & Company first reported a position in AXGN in Q4 2017 and held it in 1 quarter. The position peaked at $240K in Q4 2017. 147 funds tracked by Wall St. Rank hold AXGN as of Q1 2018.

William Blair & Company reported no remaining Axogen position as of Q1 2018 after selling out during the quarter.
William Blair & Company sold 8,492 Axogen shares in Q1 2018, an estimated $240K.
William Blair & Company first reported a position in Axogen in Q4 2017 and held it in 1 quarter.
William Blair & Company's Axogen position peaked at $240K in Q4 2017.
147 funds tracked by Wall St. Rank held Axogen as of Q1 2018.

Based on William Blair & Company's 13F filing for Q1 2018, filed 15 May 2018.